Retatrutide
A triple agonist research compound studied across GIP, GLP-1, and glucagon receptor pathways in metabolic research.
Retatrutide is a synthetic peptide studied as a triple agonist acting across GIP, GLP-1, and glucagon receptor pathways. It has become one of the most closely followed compounds in current metabolic and endocrine research literature. Supplied lyophilized, verified batch by batch via HPLC and LC-MS.
Orders placed before 2 PM CET ship the same day from within the EU, in plain, discreet packaging with no external labeling identifying the contents. Full tracking is provided once your order ships.
Every batch of Retatrutide is accompanied by a Certificate of Analysis (COA) documenting HPLC purity, identity, and sterility testing. You can preview the COA for this product above, or contact our team for the full document.